YU Qian, CAO Yu, ZHU Hua-jian, SHAO Jia-an, ZHANG Jian-kang. Research progress of small molecule proteasome activatorsJ. Acta Pharmaceutica Sinica, 2022,57(3): 605-614. doi: 10.16438/j.0513-4870.2021-1549
Citation: YU Qian, CAO Yu, ZHU Hua-jian, SHAO Jia-an, ZHANG Jian-kang. Research progress of small molecule proteasome activatorsJ. Acta Pharmaceutica Sinica, 2022,57(3): 605-614. doi: 10.16438/j.0513-4870.2021-1549

Research progress of small molecule proteasome activators

  • Proteasome controls the degradation of proteins closely related to life activities and plays a key role in the maintenance of protein homeostasis. Proteasome activities decrease with aging, followed by the overwhelming production of damaged proteins which far exceed the protein consumption. Accumulation of these proteins leads to various diseases including neurodegenerative diseases. Therefore, inducing toxic protein degradation is considered as a promising solution for the treatment of these diseases, while increasing the activity of proteasome is considered as an important strategy. However, the research in this field is still in the preliminary stage, and this review will focus on the discussion of the research progress of various small molecule proteasome activators, including research methods, pharmacological effects, structure-activity relationships and the existing problems.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return